|
1
|
Ryan CS, Juhn YJ, Kaur H, Wi CI, Ryu E,
King KS and Lachance DH: Long-term incidence of glioma in Olmsted
County, Minnesota, and disparities in postglioma survival rate: A
population-based study. Neurooncol Pract. 7:288–298.
2020.PubMed/NCBI
|
|
2
|
Sehmer EA, Hall GJ, Greenberg DC, O'Hara
C, Wallingford SC, Wright KA and Green AC: Incidence of glioma in a
northwestern region of England, 2006–2010. Neuro Oncol. 16:971–974.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Larjavaara S, Mäntylä R, Salminen T,
Haapasalo H, Raitanen J, Jääskeläinen J and Auvinen A: Incidence of
gliomas by anatomic location. Neuro Oncol. 9:319–325. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rasmussen BK, Hansen S, Laursen RJ,
Kosteljanetz M, Schultz H, Nørgård BM, Guldberg R and Gradel KO:
Epidemiology of glioma: Clinical characteristics, symptoms, and
predictors of glioma patients grade I–IV in the the Danish
Neuro-Oncology Registry. J Neurooncol. 135:571–579. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Piñeros M, Sierra MS, Izarzugaza MI and
Forman D: Descriptive epidemiology of brain and central nervous
system cancers in Central and South America. Cancer Epidemiol. 44
(Suppl 1):S141–S149. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ebbesen KK, Kjems J and Hansen TB:
Circular RNAs: Identification, biogenesis and function. Biochim
Biophys Acta. 1859:163–168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu CY and Kuo HC: The emerging roles and
functions of circular RNAs and their generation. J Biomed Sci.
26:292019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Belousova EA, Filipenko ML and Kushlinskii
NE: Circular RNA: New regulatory molecules. Bull Exp Biol Med.
164:803–815. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou J, Wang H, Chu J, Huang Q, Li G, Yan
Y, Xu T, Chen J and Wang Y: Circular RNA hsa_circ_0008344 regulates
glioblastoma cell proliferation, migration, invasion, and
apoptosis. J Clin Lab Anal. 32:e224542018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Sui X, Zhao H, Cong L, Li Y, Xin
T, Guo M and Hao W: Decreased circular RNA hsa_circ_0001649
predicts unfavorable prognosis in glioma and exerts oncogenic
properties in vitro and in vivo. Gene. 676:117–122. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhan L, Mu Z, Yang M, Zhang T and Qian L:
Elevation of circ-ITX1 upregulates interleukin 17 receptor D
expression via sponging miR8a and facilitates cell progression in
glioma. J Cell Biochem. 120:16495–16502. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yi C, Li H, Li D, Qin X, Wang J, Liu Y,
Liu Z and Zhang J: Upregulation of circular RNA circ_0034642
indicates unfavorable prognosis in glioma and facilitates cell
proliferation and invasion via the miR-1205/BATF3 axis. J Cell
Biochem. 120:13737–13744. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiong J, Wang T, Tang H, Lv Z and Liang P:
Circular RNA circMAN2B2 facilitates glioma progression by
regulating the miR-1205/S100A8 axis. J Cell Physiol.
234:22996–23004. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duan X, Liu D, Wang Y and Chen Z: Circular
RNA hsa_circ_0074362 promotes glioma cell proliferation, migration,
and invasion by attenuating the inhibition of miR-1236-3p on HOXB7
expression. DNA Cell Biol. 37:917–924. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X and Diao H: Circular RNA circ_0001946
acts as a competing endogenous RNA to inhibit glioblastoma
progression by modulating miR-671-5p and CDR1. J Cell Physiol.
234:13807–13819. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuan Y, Li J, Xiang W, Liu Y and Mao Q:
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs
to predict competing endogenous RNA networks in glioblastoma. J
Neurooncol. 137:493–502. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu J, Ye J, Zhang L, Xia L, Hu H, Jiang
H, Wan Z, Sheng F, Ma Y, Li W, et al: Differential expression of
circular RNAs in glioblastoma multiforme and its correlation with
prognosis. Transl Oncol. 10:271–279. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Glažar P, Papavasileiou P and Rajewsky N:
circBase: A database for circular RNAs. RNA. 20:1666–1670. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nikolayeva O and Robinson MD: edgeR for
Differential RNA-seq and ChIP-seq analysis: An application to stem
cell biology. Methods Mol Biol. 1150:45–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
R Development Core Team, . R: A language
and environment for statistical computing. 2015, simplehttp://www.r-project.org/February
10–2015
|
|
21
|
Dudekula DB, Panda AC, Grammatikakis I, De
S, Abdelmohsen K and Gorospe M: CircInteractome: A web tool for
exploring circular RNAs and their interacting proteins and
microRNAs. RNA Biol. 13:34–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
Starbase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale clip-seq data. Nucleic Acids
Res. 42((Database issue)): D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dweep H and Gretz N: miRWalk2.0: A
comprehensive atlas of microRNA-target interactions. Nat Methods.
12:6972015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Davis AP, Grondin CJ, Johnson RJ, Sciaky
D, McMorran R, Wiegers J, Wiegers TC and Mattingly CJ: The
Comparative Toxicogenomics Database: Update 2019. Nucleic Acids
Res. 47:D948–D954. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kohl M, Wiese S and Warscheid B:
Cytoscape: Software for visualization and analysis of biological
networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ferreira JA: The Benjamini-Hochberg method
in the case of discrete test statistics. Int J Biostat. 3:112007.
View Article : Google Scholar
|
|
28
|
Vasaikar SV, Straub P, Wang J and Zhang B:
LinkedOmics: Analyzing multi-omics data within and across 32 cancer
types. Nucleic Acids Res. 46((Database issue)): D956–D963.
2017.
|
|
29
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang W, Zhang J, Hoadley K, Kushwaha D,
Ramakrishnan V, Li S, Kang C, You Y, Jiang C, Song SW, et al:
miR-181d: A predictive glioblastoma biomarker that downregulates
MGMT expression. Neuro Oncol. 14:712–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu J, Zhang PY, Li P, Xie JW, Wang JB, Lin
JX, Chen QY, Cao LL, Huang CM and Zheng CH: Circular RNA
hsa_circ_0001368 suppresses the progression of gastric cancer by
regulating miR-6506-5p/FOXO3 axis. Biochem Biophys Res Commun.
512:29–33. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mukasa A, Ueki K, Ge X, Ishikawa S, Ide T,
Fujimaki T, Nishikawa R, Asai A, Kirino T and Aburatani H:
Selective expression of a subset of neuronal genes in
oligodendroglioma with chromosome 1p loss. Brain Pathol. 14:34–42.
2010. View Article : Google Scholar
|
|
33
|
Kashima Y, Miki T, Shibasaki T, Ozaki N,
Miyazaki M, Yano H and Seino S: Critical role of cAMP-GEFII-Rim2
complex in incretin-potentiated insulin secretion. J Biol Chem.
276:46046–46053. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fujimoto K, Shibasaki T, Yokoi N, Kashima
Y, Matsumoto M, Sasaki T, Tajima N, Iwanaga T and Seino S: Piccolo,
a Ca2+ sensor in pancreatic beta-cells. Involvement of
cAMP-GEFII.Rim2. Piccolo complex in cAMP-dependent exocytosis. J
Biol Chem. 277:50497–50502. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sani I and Albanese A: Endocrine long-term
follow-up of children with neurofibromatosis type 1 and optic
pathway glioma. Horm Res Paediatr. 87:178–188. 2017. View Article : Google Scholar
|
|
36
|
Masanori A, Takayoshi T, Koji M, Yumi A,
Ken-Ichi S and Hironobu S: Prevalence of obesity, hyperlipemia and
insulin resistance in children with suprasellar brain tumors. Clin
Pediatr Endocrinol. 16:1–9. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Anjom-Shoae J, Shayanfar M,
Mohammad-Shirazi M, Sadeghi O, Sharifi G, Siassi F and Esmaillzadeh
A: Dietary insulin index and insulin load in relation to glioma:
Findings from a case-control study. Nutr Neurosci. 29:1–9. 2019.
View Article : Google Scholar
|
|
38
|
Gong Y, Ma Y, Sinyuk M, Loganathan S,
Thompson RC, Sarkaria JN, Chen W, Lathia JD, Mobley BC, Clark SW
and Wang J: Insulin-mediated signaling promotes proliferation and
survival of glioblastoma through Akt activation. Neuro Oncol.
18:48–57. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang BC, Wang YS, Wang CH, Lin HH, Tang MJ
and Yang TL: Transient apoptosis elicited by insulin in
serum-starved glioma cells involves Fas/Fas-L and Bcl-2. Cell Biol
Int. 23:533–540. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jia G, Tang Y, Deng G, Fang D, Xie J, Yan
L and Chen Z: miR-590-5p promotes liver cancer growth and
chemotherapy resistance through directly targeting FOXO1. Am J
Transl Res. 11:2181–2193. 2019.PubMed/NCBI
|
|
41
|
Kim CW, Oh ET, Kim JM, Park JS, Lee DH,
Lee JS, Kim KK and Park HJ: Hypoxia-induced microRNA-590-5p
promotes colorectal cancer progression by modulating matrix
metalloproteinase activity. Cancer Lett. 416:31–41. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shen B, Yu S, Zhang Y, Yuan Y, Li X, Zhong
J and Feng J: miR-590-5p regulates gastric cancer cell growth and
chemosensitivity through RECK and the AKT/ERK pathway. Onco Targets
Ther. 9:6009–6019. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chu Y, Ouyang Y, Wang F, Zheng A, Bai L,
Han L, Chen Y and Wang H: MicroRNA-590 promotes cervical cancer
cell growth and invasion by targeting CHL1. J Cell Biochem.
115:847–853. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jiang X, Xiang G, Wang Y, Zhang L, Yang X,
Cao L, Peng H, Xue P and Chen D: MicroRNA-590-5p regulates
proliferation and invasion in human hepatocellular carcinoma cells
by targeting TGF-β RII. Mol Cells. 33:545–551. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen L, Wang W, Zhu S, Jin X, Wang J, Zhu
J and Zhou Y: MicroRNA-590-3p enhances the radioresistance in
glioblastoma cells by targeting LRIG1. Exp Ther Med. 14:1818–1824.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li Y, Chen D, Jin L, Liu J, Li Y, Su Z, Qi
Z, Shi M, Jiang Z, Yang S, et al: Oncogenic microRNA-142-3p is
associated with cellular migration, proliferation and apoptosis in
renal cell carcinoma. Oncol Lett. 11:1235–12341. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Qi X, Li J, Zhou C, Lv C and Tian M:
miR-142-3p suppresses SOCS6 expression and promotes cell
proliferation in nasopharyngeal carcinoma. Cell Physiol Biochem.
36:1743–1752. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gao X, Xu W, Lu T, Zhou J, Ge X and Hua D:
MicroRNA-142-3p promotes cellular invasion of colorectal cancer
cells by activation of RAC1. Technol Cancer Res Treat.
17:15330338187905082018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF,
Huang WZ, Wang WS, Jiang TF, Wu BL, Li EM and Xu LY: miR-142-3p as
a potential prognostic biomarker for esophageal squamous cell
carcinoma. J Surg Oncol. 105:175–182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hankey W, Frankel WL and Groden J:
Functions of the APC tumor suppressor protein dependent and
independent of canonical WNT signaling: Implications for
therapeutic targeting. Cancer Metastasis Rev. 37:159–172. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Naseri Z, Oskuee RK, Jaafari MR and
Forouzandeh Moghadam M: Exosome-mediated delivery of functionally
active miRNA-142-3p inhibitor reduces tumorigenicity of breast
cancer in vitro and in vivo. Int J Nanomedicine. 13:7727–7747.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wu S, Liu W and Zhou L: miR-590-3p
regulates osteogenic differentiation of human mesenchymal stem
cells by regulating APC gene. Biochem Biophys Res Commun.
478:1582–1587. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Saito-Diaz K, Benchabane H, Tiwari A, Tian
A, Li B, Thompson JJ, Hyde AS, Sawyer LM, Jodoin JN, Santos E, et
al: APC inhibits ligand-independent Wnt signaling by the clathrin
endocytic pathway. Dev Cell. 44:566–581.e8. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ghosh N, Hossain U, Mandal A and Sil PC:
The Wnt signaling pathway: A potential therapeutic target against
cancer. Ann N Y Acad Sci. 1443:54–74. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cole JM, Simmons K and Prosperi JR: Effect
of adenomatous polyposis coli loss on tumorigenic potential in
pancreatic ductal adenocarcinoma. Cells. 8:10842019. View Article : Google Scholar
|
|
56
|
Wang Y, Cao C, Fang D and Hu Y: Role of
APC-mediated MDR-1/CLCX-1 signaling pathway in ovarian tumors. J
Biol Regul Homeost Agents. 32:529–536. 2018.PubMed/NCBI
|
|
57
|
Zhang Y, Guo L, Li Y, Feng GH, Teng F, Li
W and Zhou Q: MicroRNA-494 promotes cancer progression and targets
adenomatous polyposis coli in colorectal cancer. Mol Cancer.
17:12018. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Li D, Wang Z, Chen Z, Lin L, Wang Y,
Sailike D, Luo K, Du G, Xiang X and Jiafu GD: MicroRNA-106a-5p
facilitates human glioblastoma cell proliferation and invasion by
targeting adenomatosis polyposis coli protein. Biochem Biophys Res
Commun. 481:245–250. 2016. View Article : Google Scholar : PubMed/NCBI
|
